Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 7946-7952

  Lin, Yuh Yih ^a   Huang, Jan Hung ^a   Lai, Yo Yin ^a   Huang, Han Ching ^a   Hu, Suh Woan ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E2; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; HOST; MODEL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOMES RESEARCH; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; TISSUE INJURY;

ANIMALS; BACTEROIDACEAE INFECTIONS; CELL COUNT; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; MICE; PORPHYROMONAS GINGIVALIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28444494020     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.7946-7952.2005     Document Type: Article

References (29)

1. Amiot, F., C. Fitting, K. J. Tracey, J. M. Cavaillon, and F. Dautry. 1997, Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice. Mol. Med. 3:864-875.
2. Curtis, M. A., J. Aduse-Opoku, and M. Rangarajan. 2001. Cysteine proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12:192-216.
3. Cutler, C. W., J. R. Kalmar, and C. A. Genco. 1995. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol. 3:45-51.
4. Gemmell, E., D. A. Grieco, K. Yamazaki, T. Nakajima, and G. J. Seymour. 1997. Expression of receptor beta-chain variable region by T cells in human periodontal disease. Arch. Oral Biol. 42:683-694.
5. Genco, C. A., C. W. Cutler, D. Kapczynski, K. Maloney, and R. R. Arnold. 1991. A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect. Immun. 59:1255-1263.
6. Gorska, R., H. Gregorek, J. Kowalski, A. Laskus-Perendyk, M. Syczewska, and K. Madalinski. 2003. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J. Clin. Periodontol. 30:1046-1052.
7. Graves, D. T. 1999. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin. Infect. Dis. 28:482-490.
8. Henderson, B., S. P. Nair, J. M. Ward, and M. Wilson. 2003. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu. Rev. Microbiol. 57:29-55.
9. Holt, S. C., L. Kesavalu, S. Walker, and C. A. Genco. 1999. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000;20:168-238.
10. Howell, T. H., G. Martuscelli, and J. Oringer. 1996. Polypeptide growth factors for periodontal regeneration. Curr. Opin. Periodontol. 3:149-156.
11. Kinane, D. F. 2001. Causation and pathogenesis of periodontal disease. Periodontol. 2000;25:8-20.
12. Kjeldsen, M., P. Holmstrup, R. A. Lindemann, and K. Bendtzen. 1995. Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories. J. Periodontol. 66:139-144.
13. Kollias, G. 2004. Modeling the function of tumor necrosis factor in immune pathophysiology. Autoimmun. Rev. 3(Suppl. 1):S24-S25.
14. Kornman, K. S., J. Pankow, S. Offenbacher, J. Beck, F. di Giovine, and G. W. Duff. 1999. Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J. Periodontal Res. 34:353-357.
15. Luster, M. I., P. P. Simeonova, R. Gallucci, and J. Matheson. 1999. Tumor necrosis factor alpha and toxicology. Crit. Rev. Toxicol. 29:491-511.
16. Minghetti, P. P., and W. D. Blackburn, Jr. 2000. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts. J. Rheumatol. 27:653-660.
17. Offenbacher, S. 1996. Periodontal diseases: pathogenesis. Ann. Periodontol. 1:821-878.
18. Page, R. C., S. Offenbacher, H. E. Schroeder, G. J. Seymour, and K. S. Kornman. 1997. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol. 2000; 14:216-248.
19. Scannapieco, F. A. 2004. Periodontal inflammation: from gingivitis to systemic disease? Compend. Contin. Educ. Dent. 25:16-25.
20. Scheinfeld, N. 2004. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J. Dermatol. Treat. 15:280-294.
21. Skaleric, U., C. M. Manthey, S. E. Mergenhagen, B. Gaspirc, and S. M. Wahl. 2000. Superoxide release and superoxide dismutase expression by human gingival fibroblasts. Eur. J. Oral Sci. 108:130-135.
22. Sullivan, K. E. 2003. Regulation of inflammation. Immunol. Res. 27:529-538.
23. Thorburn, A. 2004. Death receptor-induced cell killing. Cell. Signal. 16:139-144.
24. Tokoro, Y., T. Yamamoto, and K. Hara. 1996. IL-1 beta mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva. J. Oral Pathol. Med. 25:225-231.
25. Tracey, K. J. 2002. The inflammatory reflex. Nature 420:853-859.
26. Travis, J., R. Pike, T. Imamura, and J. Potempa. 1997. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J. Periodontal Res. 32:120-125.
27. Ullbro, C., C. G. Crossner, T. Nederfors, R. Parhar, F. Al Mohanna, M. C. Meikle, J. J. Reynolds, and S. Twetman. 2004. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefevre syndrome. Acta Odontol. Scand. 62:70-74.
28. Yamano, R., M. Ohara, S. Nishikubo, T. Fujiwara, T. Kawamoto, Y. Ueno, H. Komatsuzawa, K. Okuda, H. Kurihara, H. Suginaka, E. Oswald, K. Tanne, and M. Sugai. 2003. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J. Clin. Microbiol. 41:1391-1398.
29. Youn, J., S. H. Hwang, Z. Y. Ryoo, M. A. Lynes, D. J. Paik, H. S. Chung, and H. Y. Kim. 2002. Metallothionein suppresses collagen-induced arthritis via induction of TGF-beta and down-regulation of proinflammatory mediators. Clin. Exp. Immunol. 129:232-239.